---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-117226"
form_type: "8-K"
ticker: "LSH"
cik: "0001996192"
company_name: "Lakeside Holding Ltd"
filed_at: "2026-11-09T13:01:49+00:00"
generated_at: "2026-11-09T13:05:31.192766+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Quanome to issue 6,541,236 shares for about 5% stake in QAI Labs

## Summary
- Quanome Technologies signed a Nov. 4, 2026 stock purchase agreement to acquire 31,579 newly issued QAI Labs shares for 6,541,236 QNME common shares.
- The QNME shares equal about 19% of pre-issuance outstanding stock and 15.97% after issuance; the QAI Labs stake is about 5%.
- Closing is subject to regulatory consents, no material adverse change, and a Dec. 31, 2026 outside date, with termination rights.
- The parties assigned the consideration shares a $5.0 million value, implying a ~$100 million QAI Labs equity valuation; QAI Labs is pre-commercial.
- QAI Labs is developing NOVA-3, an AI-enabled multi-specific antibody discovery platform combining quantum algorithms on classical simulators with lab testing.

## SEC filing metadata
- accession: 0001213900-26-117226
- form_type: 8-K
- ticker: LSH
- cik: 0001996192
- company_name: Lakeside Holding Ltd
- filed_at: 2026-11-09T13:01:49+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 3.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1996192/000121390026117226/0001213900-26-117226-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1996192/000121390026117226/ea0310927-8k_quanome.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-117226
- JSON: https://secwatch.observer/filing/0001213900-26-117226.json
- Plain text: https://secwatch.observer/filing/0001213900-26-117226.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.